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gene, a significantly lower proportion of subjects suffering from
schizophrenia carried the rs2717 A/G genotype when compared
with healthy control subjects (p = 0.01); with respect to
rs6926279, a significant lower proportion of subjects suffering
from schizophrenia carried the C/T genotype when compared with
healthy control subjects (p = 0.02). About the EPM2A gene, we
found a lower proportion of subjects suffering from schizophrenia
carried the rs702304 G/A genotype compared to the healthy
subjects (p = 0.02). Finally, the G/G genotype and the G allele of
rs2235481 were found in a greater proportion of schizophrenia
patients compared to the healthy controls (p < 0.001 and p =
0.002, respectively). No further significant difference was
observed between the two groups concerning the remaining
genotype and allelic frequencies. With regard to the influence of
the investigated polymorphisms on clinical improvement,
repeated-measure ANOVA showed a significant effect of
rs1415744 within the EPM2A gene and clinical improvement in
the PANSS negative subscale (p = 0.02). The results remained the
same after inclusion of the covariates and were partially confirmed
in the allelic and haplotype analyses.
Conclusion: Our preliminary findings suggest that rs2717 and
rs6926279 within the NMBR gene and rs702304 and rs2235481
within the EPM2A gene could be associated with schizophrenia
susceptibility. Further, the investigated EPM2A gene variants
could be associated with the antipsychotic response of negative
symptomatology. Nonetheless, further research is needed to
confirm our findings.
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Objectives: Patients with mood disorder often show biological
rhythm-related symptoms, and evidence suggest connection
between mood disorders and different circadian genes [1]. There
is a well-known comorbidity between migraine and mood
disorders, with an overlap in their genetic factors [2], and migraine
attacks are frequently triggered by different external and internal
changes in rhythmicity – such as stress, hormonal fluctuations,
weather changes, sleep deprivation and other alterations of daily
routine [3]. Therefore, circadian genes could also play a role in
migraine. The CLOCK gene is a central component of the
circadian clock, a transcriptional activator effecting the transcrip-
tion of downstream circadian genes; and it has been associated
with mood disorders [1], thus it’s a good canditate gene for
migraine, too. Our goal was to test two functional SNPs of the
circadian CLOCK gene (rs10462028 and rs3749474) to identify
their possible influence on migraine.
Methods: 2349 subjects (720 males and 1629 females) were
recruited through general practices and advertisements from
Manchester (n = 1350) and Budapest (n = 999) (aged between
18 and 60). The probability of migraine status was measured by the
ID-Migraine Questionnaire. Chronic stress was defined by
financial status derived from the background questionnaire of
the study. Genomic DNAwas extracted from buccal mucosa cells.
The main effect of the CLOCK gene SNPs and the SNPs x chronic
stress interaction effects were tested on migraine using logistic
regressionmodels with additive, dominant and recessive models in
the total population and in both subpopulations. All statistical
models were adjusted for population, gender and age. Statistical
analyses were made using PLINK 1.9 and IBM SPSS Statistics 23.
Results: None of the SNPs showed main genetic effects on
possible migraine, but both of them showed significant interaction
with financial status on possible migraine (for rs10462028: OR =
0.79,p < 0.001; for rs3749474:OR = 1.22,p < 0.05).Thesignificant
effects of the SNPs (except one) were replicated in the subpopula-
tions (in Manchester: for rs10462028: OR = 0.52, p < 0.05; for
rs3749474: not significant; and in Budapest: for rs10462028: OR =
0.6, p < 0.001; for rs3749474: OR = 1.6, p < 0.05).
Conclusions: Our results suggest that the CLOCK gene might
have a role in migraine in the presence of chronic stress represented
by financial hardship. Thus, financial difficulties may trigger
migraine by influencing circadian rhythmicity. Dysregulation of
the circadian clock has also been implicated in the pathogenesis of
various diseases (such as seasonal affective disorder, hyperten-
sion, asthma and cancer) [4], therefore a stress-elicited circadian
dysregulation in migraineurs could be a factor in the onset of other
illnesses, too. The investigated SNPs in the CLOCK gene affect
miRNA binding, and evidence suggest that miRNAs have a
distinct role in clock physiology, therefore they present novel
therapeutic targets for diseases related to the circadian rhythm [4].
Further investigation of the potential functions of circadian genes
in the pathophysiology of migraine, especially in patients with
serious life stressors, may provide new treatment strategies.
References
[1] Soria,V.,Martinez-Amoros, E., Escaramis,G.,Valero, J., Perez-Egea, R.,
Garcia, C., Gutierrez-Zotes, A., Puigdemont, D., Bayes, M., Crespo, J.
M.,Martorell, L., Vilella, E., Labad,A.,Vallejo, J., Perez,V.,Menchon, J.
M., Estivill, X., Gratacos, M., Urretavizcaya, M., 2010. Differential
association of circadian genes with mood disorders: CRY1 and NPAS2
are associatedwith unipolar major depression and CLOCK andVIPwith
bipolar disorder. Neuropsychopharmacology 35, 1279–1289.
[2] Ligthart, L., Hottenga, J.J., Lewis, C.M., Farmer, A.E., Craig, I.W.,
Breen, G.,Willemsen, G., Vink, J.M., Middeldorp, C.M., Byrne, E.M.,
Heath, A.C., Madden, P.A.F., Pergadia, M.L., Montgomery, G.W.,
Martin, N.G., Penninx, B.W.J.H., McGuffin, P., Boomsma, D.I.,
Nyholt, D.R., 2014. Genetic risk score analysis indicates migrainewith
and without comorbid depression are genetically different disorders.
Hum Genet 133, 173–186.
[3] Baldacci, F., Vedovello, M., Ulivi, M., Vergallo, A., Poletti, M.,
Borelli, P., Cipriani, G., Nuti, A., Bonuccelli, U., 2013. Triggers in
allodynic and non-allodynic migraineurs. A clinic setting study.
Headache 53, 152–160.
P.1.a Basic and clinical neuroscience – Genetics and epigeneticsS578
[4] Hansen, K.F., Sakamoto, K., Obrietan, K., 2011. MicroRNAs: a
potential interface between the circadian clock and human health.
Genom Med 3, 10–17.
Disclosure statement: The study was supported by the MTA-SE-NAP B
Genetic Brain Imaging Migraine Research Group (KTIA_NAP_13-2-
2015-0001) by the National Development Agency (KTIA_NAP_13-1-
2013-0001), Hungarian Brain Research Program (KTIA_13_NAP-A-II/
14) and the MTA-SE Neuropsychopharmacology and Neurochemistry
Research Group.
P.1.a.005 Genome-wide gene-based tests replicate
the association of the SORCS3 gene with
neuroticism
N. Eszlari1*, A. Millinghoffer2, P. Petschner1, X. Gonda3,
D. Baksa4, A.J. Pulay5, J. Rethelyi6, R. Elliott7, I.M. Anderson7,
J.F.W. Deakin7, P. Antal2, G. Bagdy1, G. Juhasz1 1Semmelweis
University, Department of Pharmacodynamics, Budapest,
Hungary; 2Budapest University of Technology and Economics,
Department of Measurement and Information Systems, Budapest,
Hungary; 3Semmelweis University, Department of Psychiatry and
Psychotherapy, Kutvolgyi Clinical Centre, Budapest, Hungary;
4Hungarian Academy of Sciences, Semmelweis University,
MTA-SE-NAP B Genetic Brain Imaging Migraine Research
Group, Budapest, Hungary; 5Semmelweis University, Department
of Psychiatry and Psychotherapy, Budapest, Hungary;
6Hungarian Academy of Sciences, Semmelweis University,
MTA-SE NAP-BMolecular Psychiatry Research Group, Budapest,
Hungary; 7University of Manchester, Institute of Brain Behaviour
and Mental Health, Neuroscience and Psychiatry Unit,
Manchester, United Kingdom
Introduction: Among the Big Five personality dimensions,
neuroticism has the strongest phenotypic as well as genotypic
correlations with lifetime major depression [1]. Previous genome-
wide association studies (GWAS) have applied SNP (single
nucleotide polymorphism)-based and gene-based tests to find
SNPs and genes in the background of neuroticism. However, in
those GWAS implementing gene-based tests, only onemethodwas
used.
Aim: In the present study, we conducted a GWAS on
neuroticism, both with SNP-based and with five distinct gene-
based tests.
Methods: Among a European white sample (N = 1770)
recruited in Budapest and Manchester, linear regression models
were run with each of the genome-wide genotyped 86,232 SNPs,
gender, age and the top ten principal components of the genome as
predictor variables, and neuroticism as the outcome. The yielded
SNP-based results then served as the input of the gene-based
GATES test. False discovery rate (FDR) method was used to
correct for multiple testing both at the SNP- and the gene-level,
with an error rate of 0.05. As post hoc tests without correction, four
additional gene-based tests were implemented according to
FORGE and SETSCREEN methods.
Results: 63,326 SNPs (64.46% of all) reside within genes, and
18,264 genes were identified. None of the SNPs or genes survives
the FDR correction. However, among the more than fifty genes
identified as candidates in previous neuroticism GWAS studies
either by a gene-based test or by locating any significant SNP into
a gene, we found that TACC2 (transforming acidic coiled-coil
containing protein 2) and SORCS3 (sortilin related VPS10 domain
containing receptor 3) genes are nominally significant (p ≤ 0.05)
to neuroticism in our study (Table 1). Nonetheless, TACC2 does
not show any significant (p ≤ 0.05) association with neuroticism
according to our post hoc gene-based tests, but the effect of
SORCS3 is significant in all of the four tests (Table 1).
Conclusion:Our GWAS study is the first one to report the gene-
level association of the SORCS3 gene with neuroticism, since the
original GWAS from which we chose this gene for replication did
not use a gene-based, but only a SNP-based approach [2].
Moreover, we further underpinned this gene-personality associ-
ation with four additional methods. SORCS3 SNPs have been
reported to be associated with Alzheimer’s disease, and the
expression level of this gene was lower in Alzheimer’s patients’
than in controls’ amygdala, but there was no such between-group
difference in occipital lobe or cerebellum [3]. Given the well-
grounded importance of the amygdala in depression risk and
neuroticism, further studies are needed to elucidate the precise role
of the SORCS3 gene and SORCS3 protein in neuroticism and
depression, and to reveal whether or not their association with
Alzheimer’s disease is mediated by this personality trait.
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Table 1. (Abstract P.1.a.005) Gene-based methods to assess the association of neuroticism with two genes reported in previous GWAS.
GATES method Post hoc tests
Gene Nominal P value FDR-corrected P value FORGE PSidak FORGE Zfix SETSCREEN P1 SETSCREEN P2
TACC2 0.0449 0.9696 0.9089 0.9857 0.9599 0.9698
SORCS3 0.0130 0.9296 0.0201 0.0106 0.0177 0.0437
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